Drugs / allogenic Umbilical Cord-derived Mesenchymal Stem Cell
allogenic Umbilical Cord-derived Mesenchymal Stem Cell
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT06794294 | Jan 2025 → Jan 2027 expected | rotator cuff syndrome | Seoul National University Hospital | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06817616 | Jan 2025 → Apr 2026 overdue | rotator cuff syndrome | Korea University Anam Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | allogenic Umbilical Cord-derived Mesenchymal Stem Cell | “Biological: Allogenic Umbilical Cord - derived Mesenchymal Stem Cell” NCT06817616 ↗ |
| Modality | Cell therapy | “Biological: Allogenic Umbilical Cord - derived Mesenchymal Stem Cell” NCT06794294 ↗ |
| Route | Other | “Injection technique: Injection into the lesion by investigator” NCT06794294 ↗ |